Track accepted paper

Journal Metrics

Source Normalized Impact per Paper (SNIP): 0.676ℹSource Normalized Impact per Paper (SNIP):2014: 0.676SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.

SCImago Journal Rank (SJR): 1.006ℹ

SCImago Journal Rank (SJR):2014: 1.006SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.

I. Stagljar

Editor, Biochemical and Biophysical Research Communications

University of Toronto, Toronto, Ontario, Canada

Igor Stagljar completed his undergraduate degree in the field of Molecular Biology from the University of Zagreb in Croatia in 1990. He then moved to Switzerland where he received his MSc & PhD degrees in Molecular Biology from the Swiss Federal School of Technology (ETH) in Zurich. From 1995-1999, Igor did his Post Doctoral work in the Department of Molecular Biology at the University of Zurich, later becoming a Senior Research Associate at the Institute of Veterinary Biochemistry and Molecular Biology in the University of Zurich. In 2001, Igor was a Visiting Scientist at the Department of Genome Sciences of the University of Washington in Seattle, where he worked in the lab of Dr. Stanley Fields, the inventor of the yeast two-hybrid technology. From 2002 to 2005, Igor maintained an Assistant Professor position at the University of Zurich. During this time, his lab developed the now patented membrane yeast two-hybrid technology (MYTH).

Igor was recruited as an Associate Professor with tenure to the University of Toronto in the summer of 2005. Furthermore in 2010, he was promoted to the rank of full Professor in the Departments of Biochemistry and Molecular Genetics at the University of Toronto. His lab is located in the Donnelly Centre, a cutting-edge, interdisciplinary research Centre in the heart of Toronto's research district. Igor is an expert on the development of methods to investigate protein-protein interactions and his lab is currently involved in various projects to map how integral membrane proteins interact to produce either healthy or diseased cells.

He has served as member or scientific officer of many peer review committees and scientific advisory boards for the national and international funding agencies as well as pharmaceutical and biotechnology companies. In addition, Igor also co-founded Dualsystems Biotech, one of the world-leading interactive proteomics companies whose focus is on protein-protein interaction services, including various yeast-based two-hybrid screenings and mammalian cell-based protein complex identifications.

Send an email to I. Stagljar

To send an email to I. Stagljar please complete the short form below.
Please note that all enquiries should relate specifically to Biochemical and Biophysical Research Communications.
All the fields are required so please make sure you complete them all otherwise we won't be able to send your message.